Xilio Therapeutics, Inc. earnings per share and revenue

XLO earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.25 USD which accounts for 10.81% surprise. Company revenue for the same period amounts to 2.28 M USD despite the estimated figure of 3.30 M USD. Estimated earnings per share for the next quarter are -0.22 USD, and revenue is expected to reach 3.30 M USD. Also watch annual changes over time to get a bigger picture of XLO earnings per share and revenue dynamics.